Current perspectives on exosomes in the diagnosis and treatment of hepatocellular carcinoma (review). Issue 4 (3rd April 2021)

• Record Type: Journal Article
• Authors: Xue, Dongdong; Han, Jingzhao; Liu, Yifan; Tuo, Hongfang; Peng, Yanhui
• Is Part Of: Cancer biology & therapy. Volume 22:Issue 4(2021)
• Page Start: 279
• Page End: 290
• Publication Date: 2021-04-03
• Subjects: Hepatocellular carcinoma -- exosomes -- microenvironment -- drug resistance -- targeted treatment; 616.99406
• DOI: 10.1080/15384047.2021.1898728
• Languages: English
• ISSNs: 1538-4047

Abstract

ABSTRACT: The prognosis of hepatocellular carcinoma (HCC), a malignant tumor, is poor. Tumor recurrence and metastasis are the major challenges for the treatment of HCC. Various studies have demonstrated that exosomes, which are loaded with various biomolecules including nucleic acids, lipids, and proteins are involved in the recurrence and metastasis of HCC. Additionally, exosomes mediate various biological processes, such as immune response, cell apoptosis, angiogenesis, thrombosis, autophagy, and intercellular signal transduction. In cancer, exosomes regulate cancer cell differentiation, development, and drug resistance. Circular RNAs, microRNAs, and proteins in the exosomes can serve as early diagnostic and prognostic markers for HCC. As exosomes are characterized by low immunogenicity and high stability in the tissues and circulation, they can be used to deliver the drugs in cancer therapies.